We represented PANTHERx, a specialty pharmacy specializing in orphan drugs and rare diseases, in its sale to Centene Corporation, a diversified, multi-national healthcare enterprise that provides a portfolio of services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Terms of the transaction were not disclosed.
PANTHERx Sells to Centene
Client Type: Private Company
You Also May Be Interested In:
-
Representation of New Harbor Capital’s portfolio company Psych Associates of Maryland, the largest outpatient mental health group in Maryland, in its acquisition of Comprehensive Behavioral Health, a leading multidisciplinary mental health treatment provider. Terms of the transaction were not disclosed.
-
Representation of NVision Eye Centers, one of the largest providers of LASIK and cataract surgery in the U.S, in its acquisition of Turner Eye Institute, a LASIK and other eye surgery center. Terms of the transaction were not disclosed.
-
Representation of Haven Behavioral Health, who operates acute care behavioral hospitals across the country, in its acquisition of WW IOP, LLC, a Boise, ID outpatient mental health clinic. Terms of the transaction were not disclosed.